NPI: 1336443282 · UKIAH, CA 95482 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/07/2011
Authorized official SCHULTZ, DONOVAN controls 20+ related entities in our dataset. Read more
| Authorized Official | SCHULTZ, DONOVAN (PRESIDENT) |
| NPI Enumeration Date | 01/07/2011 |
Other providers sharing the same authorized official: SCHULTZ, DONOVAN
| Provider | City | State | Total Paid |
|---|---|---|---|
| DIALYSIS CLINIC INC. | JACKSONVILLE | FL | $5.57M |
| DIALYSIS CLINIC INC. | ALBUQUERQUE | NM | $4.94M |
| DIALYSIS CLINIC INC. | CINCINNATI | OH | $4.29M |
| DIALYSIS CLINIC INC. | OMAHA | NE | $3.91M |
| DIALYSIS CLINIC INC. | SACRAMENTO | CA | $3.90M |
| DIALYSIS CLINIC INC. | PHILADELPHIA | PA | $2.95M |
| DIALYSIS CLINIC INC. | SACRAMENTO | CA | $2.60M |
| DIALYSIS CLINIC INC. | BOSTON | MA | $2.18M |
| DIALYSIS CLINIC INC. | NASHVILLE | TN | $2.11M |
| DIALYSIS CLINIC INC. | TUCSON | AZ | $1.92M |
| DIALYSIS CLINIC INC. | CORBIN | KY | $1.87M |
| DIALYSIS CLINIC INC. | GRANTS | NM | $1.69M |
| DIALYSIS CLINIC INC. | SKOWHEGAN | ME | $1.51M |
| DIALYSIS CLINIC, INC. | EAST LIVERPOOL | OH | $1.50M |
| DIALYSIS CLINIC INC. | CINCINNATI | OH | $1.50M |
| DIALYSIS CLINIC INC. | SYRACUSE | NY | $1.45M |
| DIALYSIS CLINIC INC. | NASHVILLE | TN | $1.44M |
| DIALYSIS CLINIC INC. | CHATTANOOGA | TN | $1.35M |
| DIALYSIS CLINIC, INC. | JACKSON | TN | $1.28M |
| DIALYSIS CLINIC INC. | LEBANON | TN | $1.02M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 567 | $411K |
| 2019 | 601 | $433K |
| 2020 | 1,386 | $524K |
| 2021 | 1,728 | $604K |
| 2022 | 4,200 | $793K |
| 2023 | 1,792 | $632K |
| 2024 | 1,846 | $484K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,775 | 3,715 | $2.95M |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 6,208 | 526 | $894K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 157 | 36 | $19K |
| Q5105 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units | 510 | 54 | $11K |
| J2501 | Injection, paricalcitol, 1 mcg | 1,372 | 100 | $9K |
| J1270 | Injection, doxercalciferol, 1 mcg | 98 | 12 | $491.12 |